An Educational Resource by
Women's Cancer Initiative - Tata Memorial Hospital
SATURDAY, 9th APRIL 2016
Afatinib: Moving towards complete, potent and irreversible blockade in EGFR mutation +ve NSCLC
Speaker : Dr. Shyam Aggarwal
Panel Discussion
Moderator : Dr. Purvish Parikh